Selecta Biosciences is a biopharmaceutical company developing the first generation of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Our proprietary product platform technology combines recent advances in immunobiology with cutting-edge nanotechnology to develop targeted immunomodulatory nanoparticles.
Current Team (9)Update
General Counsel and Corporate Secretary
President and CEO
Founder, Board of Directors and Vice Chairman on the Board
Senior Vice President Pharmaceutical Research, Development and Operations
Chief Scientific Officer
Vice President Finance
CEO of Selecta RUS
Funding Rounds (7) - $115.7MUpdate
Board Members and Advisors (8)Update
$6 BN russian investment fund
NIDA's mission is to lead the Nation in bringing the power of science to bear on drug abuse...
Realizing entrepreneurial innovation is the mission of Flagship Ventures. The firm operates...
Venture capital firm
OrbiMed is a healthcare-dedicated investment firm, with approximately $5 billion in assets under...
Polaris Partners is a venture company investing in digital media, life sciences, and enterprise...
480 Arsenal St
Watertown, MA 02472